Clinical trials
Phase 3 Osteoporosis trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Asahi Kasei Therapeutics Corporation | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Ligand Pharmaceuticals | 1 |
| Ono Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis | 6 |
| Bone Diseases | 1 |
| Bone Diseases, Metabolic | 1 |
| Musculoskeletal Diseases | 1 |
| Osteoporosis, Postmenopausal | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.